AP MOLLER-MAERSK A/S-B (DP4B.DE) Fundamental Analysis & Valuation

Q: Can you provide the ChartMill fundamental rating for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a fundamental rating of 3 / 10 to DP4B.DE.

FRA:DP4B • DK0010244508

2128 EUR

-3 (-0.14%)

Last: Apr 7, 2026, 07:00 PM

This DP4B.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. DP4B.DE Profitability Analysis

1.1 Basic Checks

DP4B had positive earnings in the past year.
In the past year DP4B had a positive cash flow from operations.
DP4B had positive earnings in each of the past 5 years.
In the past 5 years DP4B always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of DP4B (3.08%) is worse than 77.78% of its industry peers.
The Return On Equity of DP4B (4.90%) is worse than 83.33% of its industry peers.
DP4B has a Return On Invested Capital of 3.39%. This is in the lower half of the industry: DP4B underperforms 72.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DP4B is below the industry average of 8.48%.

		Industry Rank	Sector Rank
ROA	3.08%
ROE	4.9%
ROIC	3.39%

ROA(3y)4.89%

ROA(5y)14.13%

ROE(3y)7.57%

ROE(5y)21.73%

ROIC(3y)4.88%

ROIC(5y)15.33%

1.3 Margins

With a Profit Margin value of 5.05%, DP4B is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of DP4B has declined.
DP4B has a Operating Margin of 5.30%. This is in the lower half of the industry: DP4B underperforms 77.78% of its industry peers.
In the last couple of years the Operating Margin of DP4B has declined.
With a Gross Margin value of 21.21%, DP4B is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
DP4B's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	5.3%
PM (TTM)	5.05%
GM	21.21%

OM growth 3Y-48.33%

OM growth 5Y-11.33%

PM growth 3Y-47.96%

PM growth 5Y-6.78%

GM growth 3Y-23.21%

GM growth 5Y-1.8%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. DP4B.DE Health Analysis

2.1 Basic Checks

DP4B has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DP4B has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DP4B has less shares outstanding
DP4B has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.50 indicates that DP4B is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.50, DP4B is in line with its industry, outperforming 55.56% of the companies in the same industry.
The Debt to FCF ratio of DP4B is 3.81, which is a good value as it means it would take DP4B, 3.81 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DP4B (3.81) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.27 indicates that DP4B is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.27, DP4B is in the better half of the industry, outperforming 66.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	3.81
Altman-Z	2.5

ROIC/WACC0.48

WACC7.13%

2.3 Liquidity

A Current Ratio of 2.12 indicates that DP4B has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.12, DP4B is doing good in the industry, outperforming 72.22% of the companies in the same industry.
A Quick Ratio of 2.02 indicates that DP4B has no problem at all paying its short term obligations.
DP4B has a Quick ratio of 2.02. This is in the better half of the industry: DP4B outperforms 72.22% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.12
Quick Ratio	2.02

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. DP4B.DE Growth Analysis

3.1 Past

DP4B shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -54.45%.
The Earnings Per Share has been growing slightly by 3.98% on average over the past years.
DP4B shows a decrease in Revenue. In the last year, the revenue decreased by -2.69%.
The Revenue has been growing slightly by 6.32% on average over the past years.

EPS 1Y (TTM)-54.45%

EPS 3Y-51.97%

EPS 5Y3.98%

EPS Q2Q%-103.58%

Revenue 1Y (TTM)-2.69%

Revenue growth 3Y-12.84%

Revenue growth 5Y6.32%

Sales Q2Q%-8.65%

3.2 Future

DP4B is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.51% yearly.
The Revenue is expected to grow by 2.54% on average over the next years.

EPS Next Y-104.3%

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

EPS Next 5Y-5.51%

Revenue Next Year-4.76%

Revenue Next 2Y-1.93%

Revenue Next 3Y0.15%

Revenue Next 5Y2.54%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks Show best growing peers

4. DP4B.DE Valuation Analysis

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.95, which indicates a correct valuation of DP4B.
Based on the Price/Earnings ratio, DP4B is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
DP4B is valuated rather cheaply when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for DP4B. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	13.95
Fwd PE	N/A

4.2 Price Multiples

DP4B's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DP4B is cheaper than 88.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DP4B is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	7.85
EV/EBITDA	4.87

4.3 Compensation for Growth

DP4B's earnings are expected to decrease with -69.32% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)3.5

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. DP4B.DE Dividend Analysis

5.1 Amount

DP4B has a Yearly Dividend Yield of 2.98%.
Compared to an average industry Dividend Yield of 6.08, DP4B is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 1.89, DP4B pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	2.98%

5.2 History

On average, the dividend of DP4B grows each year by 50.43%, which is quite nice.

Dividend Growth(5Y)50.43%

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

93.47% of the earnings are spent on dividend by DP4B. This is not a sustainable payout ratio.
DP4B's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.

DP93.47%

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

More info and screens

Find the best dividend stocks Show peers with best dividend

DP4B.DE Fundamentals: All Metrics, Ratios and Statistics

AP MOLLER-MAERSK A/S-B

FRA:DP4B (4/7/2026, 7:00:00 PM)

2128

-3 (-0.14%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupTransportation

GICS IndustryMarine Transportation

Earnings (Last)02-05 2026-02-05/bmo

Earnings (Next)05-08 2026-05-08/bmo

Inst Owners21.14%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap33.69B

Revenue(TTM)53.99B

Net Income(TTM)2.73B

Analysts40

Price Target1733.41 (-18.54%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.98%

Yearly Dividend145.51

Dividend Growth(5Y)50.43%

DP93.47%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-63.1%

Min EPS beat(2)-129.84%

Max EPS beat(2)3.65%

EPS beat(4)2

Avg EPS beat(4)-23.23%

Min EPS beat(4)-129.84%

Max EPS beat(4)33.56%

EPS beat(8)5

Avg EPS beat(8)26.48%

EPS beat(12)9

Avg EPS beat(12)31.84%

EPS beat(16)11

Avg EPS beat(16)25.48%

Revenue beat(2)2

Avg Revenue beat(2)0.51%

Min Revenue beat(2)0.38%

Max Revenue beat(2)0.65%

Revenue beat(4)3

Avg Revenue beat(4)0.35%

Min Revenue beat(4)-1.86%

Max Revenue beat(4)2.23%

Revenue beat(8)5

Avg Revenue beat(8)0.16%

Revenue beat(12)5

Avg Revenue beat(12)-1.44%

Revenue beat(16)7

Avg Revenue beat(16)-1.28%

PT rev (1m)0%

PT rev (3m)5.25%

EPS NQ rev (1m)-2963.92%

EPS NQ rev (3m)45.52%

EPS NY rev (1m)0%

EPS NY rev (3m)-161.01%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)4.08%

Revenue NY rev (1m)1.16%

Revenue NY rev (3m)1.11%

Valuation

		Industry Rank	Sector Rank
PE	13.95
Fwd PE	N/A
P/S	0.72
P/FCF	7.85
P/OCF	3.99
P/B	0.7
P/tB	0.86
EV/EBITDA	4.87

EPS(TTM)152.53

EY7.17%

EPS(NY)-6.56

Fwd EYN/A

FCF(TTM)271.23

FCFY12.75%

OCF(TTM)533.54

OCFY25.07%

SpS2951.01

BVpS3038.09

TBVpS2468.52

PEG (NY)N/A

PEG (5Y)3.5

Graham Number3229.01

Profitability

		Industry Rank	Sector Rank
ROA	3.08%
ROE	4.9%
ROCE	3.87%
ROIC	3.39%
ROICexc	3.94%
ROICexgc	4.72%
OM	5.3%
PM (TTM)	5.05%
GM	21.21%
FCFM	9.19%

ROA(3y)4.89%

ROA(5y)14.13%

ROE(3y)7.57%

ROE(5y)21.73%

ROIC(3y)4.88%

ROIC(5y)15.33%

ROICexc(3y)5.5%

ROICexc(5y)18.16%

ROICexgc(3y)6.52%

ROICexgc(5y)21.16%

ROCE(3y)5.56%

ROCE(5y)17.48%

ROICexgc growth 3Y-53.48%

ROICexgc growth 5Y-13.27%

ROICexc growth 3Y-53.64%

ROICexc growth 5Y-13.99%

OM growth 3Y-48.33%

OM growth 5Y-11.33%

PM growth 3Y-47.96%

PM growth 5Y-6.78%

GM growth 3Y-23.21%

GM growth 5Y-1.8%

F-Score4

Asset Turnover0.61

Health

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	3.81
Debt/EBITDA	1.55
Cap/Depr	72.37%
Cap/Sales	8.89%
Interest Coverage	2.83
Cash Conversion	102.86%
Profit Quality	182.09%
Current Ratio	2.12
Quick Ratio	2.02
Altman-Z	2.5

F-Score4

WACC7.13%

ROIC/WACC0.48

Cap/Depr(3y)66.27%

Cap/Depr(5y)66.65%

Cap/Sales(3y)7.87%

Cap/Sales(5y)6.7%

Profit Quality(3y)151.91%

Profit Quality(5y)133.11%

High Growth Momentum

Growth

EPS 1Y (TTM)-54.45%

EPS 3Y-51.97%

EPS 5Y3.98%

EPS Q2Q%-103.58%

EPS Next Y-104.3%

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

EPS Next 5Y-5.51%

Revenue 1Y (TTM)-2.69%

Revenue growth 3Y-12.84%

Revenue growth 5Y6.32%

Sales Q2Q%-8.65%

Revenue Next Year-4.76%

Revenue Next 2Y-1.93%

Revenue Next 3Y0.15%

Revenue Next 5Y2.54%

EBIT growth 1Y-51.61%

EBIT growth 3Y-54.96%

EBIT growth 5Y-5.73%

EBIT Next Year95.06%

EBIT Next 3Y30%

EBIT Next 5Y29.47%

FCF growth 1Y-31.15%

FCF growth 3Y-45.3%

FCF growth 5Y-5.27%

OCF growth 1Y-14.44%

OCF growth 3Y-34.34%

OCF growth 5Y4.51%

AP MOLLER-MAERSK A/S-B / DP4B.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a fundamental rating of 3 / 10 to DP4B.DE.

Can you provide the valuation status for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a valuation rating of 3 / 10 to AP MOLLER-MAERSK A/S-B (DP4B.DE). This can be considered as Overvalued.

What is the profitability of DP4B stock?

AP MOLLER-MAERSK A/S-B (DP4B.DE) has a profitability rating of 2 / 10.

What are the PE and PB ratios of AP MOLLER-MAERSK A/S-B (DP4B.DE) stock?

The Price/Earnings (PE) ratio for AP MOLLER-MAERSK A/S-B (DP4B.DE) is 13.95 and the Price/Book (PB) ratio is 0.7.

How financially healthy is AP MOLLER-MAERSK A/S-B?

The financial health rating of AP MOLLER-MAERSK A/S-B (DP4B.DE) is 6 / 10.